I3 Verticals [IIIV] vs Oracle [ORCL] Detailed Stock Comparison
I3 Verticals
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: I3 Verticals wins in 9 metrics, Oracle wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | I3 Verticals | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 65.90 | 54.12 | Oracle |
| Price-to-Book Ratio | 1.96 | 32.31 | I3 Verticals |
| Debt-to-Equity Ratio | 1.06 | 519.59 | I3 Verticals |
| PEG Ratio | -0.25 | 32.88 | I3 Verticals |
| EV/EBITDA | 22.57 | 32.34 | I3 Verticals |
| Profit Margin (TTM) | 53.45% | 21.68% | I3 Verticals |
| Operating Margin (TTM) | -9.19% | 32.48% | Oracle |
| EBITDA Margin (TTM) | N/A | 32.48% | N/A |
| Return on Equity | 3.07% | 82.38% | Oracle |
| Return on Assets (TTM) | 0.92% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $33.45M | $-394.00M | I3 Verticals |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 35.66% | 65.77% | Oracle |
| Price-to-Sales Ratio (TTM) | 4.11 | 11.52 | I3 Verticals |
| Enterprise Value | $832.90M | $759.52B | Oracle |
| EV/Revenue Ratio | 3.36 | 13.23 | I3 Verticals |
| Gross Profit Margin (TTM) | 67.76% | 70.19% | Oracle |
| Revenue per Share (TTM) | $10 | $21 | Oracle |
| Earnings per Share (Diluted) | $0.48 | $4.35 | Oracle |
| Beta (Stock Volatility) | 1.33 | 1.43 | I3 Verticals |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
I3 Verticals vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| I3 Verticals | 0.75% | -1.09% | 6.29% | 21.36% | 17.51% | 31.99% |
| Oracle | 0.67% | -0.17% | -5.45% | 44.65% | 35.80% | 41.06% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| I3 Verticals | 35.66% | 36.93% | 16.66% | 78.20% | 78.20% | 78.20% |
| Oracle | 65.77% | 213.62% | 320.26% | 545.74% | 921.86% | 1,649.14% |
Performance & Financial Health Analysis: I3 Verticals vs Oracle
| Metric | IIIV | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.02B | $661.23B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 285,640 | 10,302,137 |
| 90 Day Avg. Volume | 300,293 | 10,197,732 |
| Last Close | $30.97 | $235.77 |
| 52 Week Range | $20.42 - $33.44 | $118.86 - $260.87 |
| % from 52W High | -7.39% | -9.62% |
| All-Time High | $37.85 (Feb 10, 2020) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -18.18% | -9.62% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.11% |
| Quarterly Earnings Growth | -0.07% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.53% | 0.22% |
| Operating Margin (TTM) | -0.09% | 0.32% |
| Return on Equity (TTM) | 0.03% | 0.82% |
| Debt to Equity (MRQ) | 1.06 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $16.12 | $7.29 |
| Cash per Share (MRQ) | $2.33 | $3.99 |
| Operating Cash Flow (TTM) | $6.87M | $20.82B |
| Levered Free Cash Flow (TTM) | $266.08M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: I3 Verticals vs Oracle
| Metric | IIIV | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 65.90 | 54.12 |
| Forward P/E | 23.96 | 32.88 |
| PEG Ratio | -0.25 | 32.88 |
| Price to Sales (TTM) | 4.11 | 11.52 |
| Price to Book (MRQ) | 1.96 | 32.31 |
| Market Capitalization | ||
| Market Capitalization | $1.02B | $661.23B |
| Enterprise Value | $832.90M | $759.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.36 | 13.23 |
| Enterprise to EBITDA | 22.57 | 32.34 |
| Risk & Other Metrics | ||
| Beta | 1.33 | 1.43 |
| Book Value per Share (MRQ) | $16.12 | $7.29 |
Financial Statements Comparison: I3 Verticals vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IIIV | ORCL |
|---|---|---|
| Revenue/Sales | $63.06M | $15.90B |
| Cost of Goods Sold | $22.19M | $4.74B |
| Gross Profit | $40.87M | $11.16B |
| Research & Development | N/A | $2.65B |
| Operating Income (EBIT) | $4.35M | $5.19B |
| EBITDA | $12.82M | $7.00B |
| Pre-Tax Income | $4.15M | $4.15B |
| Income Tax | $3.05M | $725.00M |
| Net Income (Profit) | $769,000 | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IIIV | ORCL |
|---|---|---|
| Cash & Equivalents | $55.54M | $10.79B |
| Total Current Assets | $117.78M | $24.58B |
| Total Current Liabilities | $58.21M | $32.64B |
| Long-Term Debt | $3.37M | $96.83B |
| Total Shareholders Equity | $511.12M | $20.97B |
| Retained Earnings | $115.18M | $-15.48B |
| Property, Plant & Equipment | $12.50M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IIIV | ORCL |
|---|---|---|
| Operating Cash Flow | $5.53M | $5.93B |
| Capital Expenditures | $38,000 | N/A |
| Free Cash Flow | $-29.42M | $-2.92B |
| Debt Repayment | $-48.53M | $-6.07B |
| Common Stock Repurchase | $-308,000 | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | IIIV | ORCL |
|---|---|---|
| Shares Short | 2.47M | 20.69M |
| Short Ratio | 7.58 | 1.58 |
| Short % of Float | 0.17% | 0.01% |
| Average Daily Volume (10 Day) | 285,640 | 10,302,137 |
| Average Daily Volume (90 Day) | 300,293 | 10,197,732 |
| Shares Outstanding | 23.88M | 2.81B |
| Float Shares | 20.92M | 1.64B |
| % Held by Insiders | 0.02% | 0.42% |
| % Held by Institutions | 1.27% | 0.45% |
Dividend Analysis & Yield Comparison: I3 Verticals vs Oracle
| Metric | IIIV | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |